Literature DB >> 34689176

Long-term survival in a fraction of patients with metastatic breast cancer who received consolidation therapy with high-dose chemotherapy and autologous stem cell transplant between 2000 and 2015: an EBMT registry-based study.

Massimo Martino1, Annalisa Pitino2, Mercedes Gori2, Patrice Viens3, Salvatore Siena4, Giovanni Tripepi5, Filippo Antonio Canale6, Alberto Ballestrero7, Claudio Zamagni8, Maurizio Musso9, Alberto Zambelli10,11, Peter Dreger12, Manuela Badoglio13, Simona Secondino14, Giuseppe Console6, Christian Chabannon15, Paolo Pedrazzoli14,16.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34689176     DOI： 10.1038/s41409-021-01503-7

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  5 in total

1.  A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy.

Authors:  J J Vredenburgh; B Madan; D Coniglio; M Ross; G Broadwater; D Niedzwiecki; J Edwards; L Marks; R Vandemark; C McDonald; M L Affronti; W P Peters
Journal:  Bone Marrow Transplant       Date:  2006-06       Impact factor: 5.483

2.  Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemotherapy alone.

Authors:  James J Vredenburgh; David Coniglio; Gloria Broadwater; Roy B Jones; Maureen Ross; Elizabeth J Shpall; Atif Hussein; David Rizzieri; Larry B Marks; Colleen Gilbert; Mary Lou Affronti; Sarah Moore; Carolyn McDonald; William P Petros; William P Peters
Journal:  Biol Blood Marrow Transplant       Date:  2006-02       Impact factor: 5.742

3.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

4.  Change in Survival in Metastatic Breast Cancer with Treatment Advances: Meta-Analysis and Systematic Review.

Authors:  Jennifer L Caswell-Jin; Sylvia K Plevritis; Lu Tian; Christopher J Cadham; Cong Xu; Natasha K Stout; George W Sledge; Jeanne S Mandelblatt; Allison W Kurian
Journal:  JNCI Cancer Spectr       Date:  2018-12-24

5.  Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years.

Authors:  Jakob R Passweg; Helen Baldomero; Christian Chabannon; Grzegorz W Basak; Rafael de la Cámara; Selim Corbacioglu; Harry Dolstra; Rafael Duarte; Bertram Glass; Raffaella Greco; Arjan C Lankester; Mohamad Mohty; Régis Peffault de Latour; John A Snowden; Ibrahim Yakoub-Agha; Nicolaus Kröger
Journal:  Bone Marrow Transplant       Date:  2021-02-23       Impact factor: 5.483
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.